Category: Uncategorized

Dr. Hersh and colleagues have begun to analyze data from their patients who underwent CXL as part of an FDA clinical trial in order to devise a CXL algorithm. The article below was published in the June 1, 2012 issue of Ophthalmology Times.

Dr. Hersh visited Moscow hospital this week to review results of new corneal cross-linking technique.

In the June issue of Journal of Refractive Surgery, Dr. Hersh’s article, “Effect of Topographic Cone Location on Outcomes of Corneal Collagen Cross-linking for Keratoconus and Corneal Ectasia.” Corneal collagen cross-linking is a treatment designed to decrease the progression of keratoconus and corneal ectasia. The purpose of the article is to assess the effect of […]

Dr. Hersh discusses positive early outcomes for cross-linking with a corneal implant for keratoconus and ectasia in an article for Ocular Surgery News. At the American Academy of Opthalmology meeting, Dr. Hersh presented his early results iof patients who were treated with Intacs and CXL in either combination or subquential. Dr. Hersh discusses Early outcomes […]

Dr. Hersh will be giving a lecture entitled “Clinical Timecourse of Corneal Collagen Crosslinking” at the annual meeting of the Association of Research in Vision and Ophthalmology on Wedneday May 9. He will be presenting results of his work on the corneal crosslinking procedure which is designed to treat keratoconus. Keratoconus is a disorder that […]